$UNH

Conway Patrick Hugh sold $456K of UNH

Conway Patrick Hugh (Chief Executive Officer, Optum) sold 1,169 shares of UNITEDHEALTH GROUP INC (UNH) at $390.00 ($0.46M total) on 2026-08-21.

Original reporting
SEC EDGAR · Conway Patrick Hugh
Published Aug 25, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$UNH
Neutral
high confidence
Mentioned
$UNH
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UNHNeutralLow
01

Why it matters

Routine insider sale with modest dollar amount; unlikely to move market.

02

Market read

Provides transparency on insider activity; minimal trading relevance.

03

What to watch

CEO retains a sizable stake; no change in control.

Relevance 4/10Novelty 4/10Timing: filed Aug 25, 2026

Background

Form 4 filing reports insider transactions required by SEC.

Company-level read

Ticker impact

$UNHNeutralHigh confidence
Context

CEO sold 1,169 shares for $455,910 on Aug 21, reducing his stake to 15,328 shares.

Expected impact

Minimal short-term effect on UNH price.

Evidence & confidence

Sale size is small relative to market cap and typical insider activity.

Market effects

None significant for health insurance sector.

No regional impact.

Limited to UNH investors.

Counterpoint

Sale could be personal liquidity need, not a signal of company outlook.

Key entities

  • Conway Patrick Hugh

    Chief Executive Officer, Optum, UnitedHealth Group

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UNHHighAI 8/10

UnitedHealth Group (UNH) Raises 2026 Earnings Guidance, Boosting

UnitedHealth Group (UNH) reported Q3 2026 earnings of $4.69 per share, beating estimates by $0.55. The company raised its 2026 earnings guidance to at least $20.50 per share, up from the consensus of $19.87. Revenues were $112.7 billion, slightly down year-over-year but above projections. UNH offers a 2.29% dividend yield with a 52% payout ratio and a GF Score™ of 84, indicating strong fundamentals.

$UNHMed

Notable healthcare headlines for the week: J&J, UnitedHealth, and CVS in focus

UnitedHealth (UNH) raised 2026 earnings guidance after Q3 results beat estimates, with adjusted EPS at $4.69. Johnson & Johnson (JNJ) also raised full-year guidance. Roche (RHHBY) signed a $1.16B deal for an obesity drug. STERIS (STE) to acquire Xodus Medical for $2.1B. Iambic Therapeutics (IAM) debuted with a 10% rise. CVS (CVS) agreed to pay $315M over opioid prescription allegations.

$UNHMedAI 9/10

UnitedHealth's Q3 Margins Improve, But Membership Falls: Time to Buy?

UnitedHealth Group reported Q3 2026 adjusted earnings of $4.69 per share, beating estimates and raising its annual outlook to at least $20.50 per share. Revenues were $112.7 billion, with improved margins but declining membership. Optum's earnings rose despite revenue declines. Analysts revised earnings estimates higher, but challenges include medical utilization and Medicare Advantage ratings.

$UNHHighAI 9/10

Where Could UnitedHealth's Next Growth Come From?

UnitedHealth Group (UNH) raised its 2026 EPS outlook to $20.50, citing growth in Optum Health, its care division. Optum Health serves 20M patients, with 4M in fully accountable relationships, leaving room for expansion. It generated 22.8% of UNH's 2025 revenue but saw a 3.2% revenue decline. UNH's stock rose 16.0% YoY, lagging the S&P 500. Management targets 6-8% margins for Optum Health, a multi-year effort.

$UNHMedAI 8/10

Updated Sunlight Report Reveals 2,807 Entities Across UnitedHealth Group’s Corporate Empire

The Center for Health & Democracy updated its Sunlight Report, identifying 2,807 entities under UnitedHealth Group, including 376 new ones. The report highlights UnitedHealth's $3B acquisition of Alegeus Technologies and its vast healthcare network, while noting a slowdown in acquisition growth. The report has influenced national discussions and congressional investigations.

$UNHHighAI 9/10

What Happened With UnitedHealth Stock This Week?

UnitedHealth Group (UNH) shares rose 4.5% in two days, outperforming the S&P 500. Q3 2026 earnings beat estimates at $4.69 per share, while revenue matched expectations at $113 billion. The company raised its full-year 2026 earnings forecast to at least $19.50 per share, up from $18.70. Management attributed the results to strong execution across all business segments.